Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating a Cadonilimab-based combination as first-line therapy for metastatic HER2-expressing gastric or gas…
-
FDA approval · 2024-10-18FDA Approved: VYLOY — Original Application (Astellas Pharma US, Inc.)
FDA approved the original Biologics License Application for VYLOY (zolbetuximab) from Astellas Pharma US, enabling its use for a gastric/gas…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma or Gastric/Gastroesophageal Junction Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating sitravatinib as monotherapy and in combination with tislelizumab in participants with unresectable loc…
-
CLINICAL_TRIALS research · 2024-10-18Clinical Trial Update: Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 [NA]
This clinical trial evaluates whether hepatotoxicity and neurotoxicity from oxaliplatin correlate with blood levels of HMGB1 in patients wit…
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction [Phase 2]
Phase 2 study evaluating atezolizumab and trastuzumab in combination with capecitabine and oxaliplatin for HER2-positive locally advanced re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-17Clinical Trial Update: Milademetan in Advanced/Metastatic Solid Tumors [Phase 2]
A Phase 2 trial of milademetan in advanced or metastatic solid tumors was terminated, with results posted in October 2024.
-
CLINICAL_TRIALS research · 2024-10-17Clinical Trial Update: Phase IIT Trial of SNA014 [EARLY_Phase 1]
Early-phase trial update for SNA014 by SmartNuclide Biopharma targeting gastric and gastroesophageal junction adenocarcinomas; the study is …
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Predictive Value of Air Pollution and Metabolomics for Gastric Cancer.
A clinical trial investigates whether air pollution exposure and metabolomic biomarkers can predict gastric cancer, with the study currently…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Multi-omics Based Prediction of Treatment Response to Immunotherapy Combined with Chemotherapy in Advanced Gastric/Gastroesophageal Junction Cancer.
A clinical trial is investigating multi-omics predictors of response to immunotherapy plus chemotherapy in advanced gastric cancer and gastr…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Wecare Study in Gastric Cancer Survivors [NA]
The Wecare study in gastric cancer survivors is currently recruiting at Gyeongsang National University Hospital.
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics [NA]
Clinical trial registry entry describing an ongoing targeted-agent evaluation in digestive cancers in China based on molecular characteristi…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma
This clinical trial update describes an imaging study using MRI and CT in patients with gastric cancer or gastroesophageal junction cancer. …
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
This clinical trial is evaluating the use of multi-parametric MRI and dual-energy CT imaging in patients with gastric cancer, currently recr…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma [Phase 2]
Phase 2 trial evaluating safety and efficacy of telatinib in combination with pembrolizumab in advanced gastric cancer, gastroesophageal jun…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Efficacy and Safety of Neoadjuvant Sintilimab Plus FLOT Versus Sintilimab Plus SOX Phase II Clinical Trial for Patients With Locally Advanced Gastric Cancer [Phase 2]
Phase II clinical trial evaluating neoadjuvant sintilimab plus FLOT versus sintilimab plus SOX in locally advanced gastric cancer; the study…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors [Phase 1]
Phase 1 study evaluating the safety and pharmacokinetics of PCS6422 (eniluracil) in combination with capecitabine in patients with advanced,…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines [Phase 1]
Phase 1 trial updating the addition of BAY 1895344 to FOLFIRI in patients with advanced or metastatic colorectal, gastric, and gastroesophag…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Development of a Clinical Decision Support System With Artificial Intelligence for Cancer Care
This clinical trial update describes the development of an AI-powered Clinical Decision Support System to assist cancer care and lists gastr…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors [Phase 1]
A Phase 1 study of NGM831 as a monotherapy and in combination with pembrolizumab (with or without NGM438) in advanced or metastatic solid tu…
-
CLINICAL_TRIALS research · 2024-10-09Clinical Trial Update: AI-Assisted Non-Contrast CT for Multi-Cancer Screening [NA]
An ongoing study evaluating AI-assisted non-contrast CT for multi-cancer screening is currently recruiting, covering several cancers includi…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver [NA]
A clinical trial is evaluating radical surgery for advanced gastric or gastroesophageal junction cancer with limited liver metastases. The s…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
This clinical trial update describes a study evaluating skin health and quality of life in patients receiving anti-PD-1/PD-L1/CTLA-4 inhibit…
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Early Onset and Familial Gastric Cancer Registry
Memorial Sloan Kettering Cancer Center's Early Onset and Familial Gastric Cancer Registry has completed its data collection for gastric canc…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT141 in Patients With Unresectable or Metastatic CLDN18.2-positive Gastric, Pancreatic, Ovarian and Biliary Tract Tumors [Phase 1, Phase 2]
Phase 1/2 trial of BNT141 in CLDN18.2-positive gastric, pancreatic, ovarian, and biliary tract cancers. The study was terminated and results…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 evaluation of NGM707 as a monotherapy and in combination with pembrolizumab in advanc…